CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,409 enrolled
Drug / intervention
Candesartan cilexetil/Amlodipine besilatedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02068495
NCT02068495N/ACompleted
CompareCT.gov

Unisia Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"

Takeda·observational·Posted Feb 21, 2014·Updated Jul 26, 2018

In Brief

An observational study evaluating Candesartan cilexetil/Amlodipine besilate for Hypertension. Completed, enrolled 3,409 participants.

Detailed Summary

The purpose of this survey is to investigate the safety and efficacy of long-term use of candesartan cilexetil/amlodipine besilate combination tablets (Unisia Combination Tablets) low dose (LD), high dose (HD) in participants with hypertension in the normal clinical setting.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 21, 2014
Enrollment StartJun 15, 2010
Primary CompletionMay 31, 2013
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 12.4 years ago

Interventions

Candesartan cilexetil/Amlodipine besilatedrug

Candesartan cilexetil/Amlodipine besilate tablets